Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system | |
An, Qing; Zheng, Yingxin; Zhao, Yirong; Liu, Tao; Guo, Huaizu; Zhang, Dapeng; Qian, Weizhu; Wang, Hao; Guo, Yajun; Hou, Sheng | |
刊名 | DRUG DESIGN DEVELOPMENT AND THERAPY |
2019 | |
卷号 | 13 |
关键词 | infliximab biosimilar "biobetter" CMAB008 immunogenicity |
ISSN号 | 1177-8881 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3596857 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | An, Qing,Zheng, Yingxin,Zhao, Yirong,et al. Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2019,13. |
APA | An, Qing.,Zheng, Yingxin.,Zhao, Yirong.,Liu, Tao.,Guo, Huaizu.,...&Li, Jing.(2019).Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system.DRUG DESIGN DEVELOPMENT AND THERAPY,13. |
MLA | An, Qing,et al."Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system".DRUG DESIGN DEVELOPMENT AND THERAPY 13(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论